Suchergebnisse - "Tamura, Shinobu"

PubPharm (118)

61

Remote vital signs data monitoring during home blood transfusion : A pilot study

enthalten in: Health Science Reports | 2021

von Nishikawa, A. | Fujimori, Y. | Sakano, N. | +5

62

A cluster of BK polyomavirus‐associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

enthalten in: Transplant Infectious Disease | 2021

von Hosoi, H. | Murata, S. | Suzuki, T. | +8

63

Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma

enthalten in: Hematological oncology | 2021

von Miura, K. | Tsujimura, H. | Masaki, Y. | +18

64

Disseminated carcinomatosis of the bone marrow caused by prostate cancer diagnosed with only bone marrow biopsy

enthalten in: IJU case reports | 2021

von Wakamiya, T. | Tamura, S. | Kojima, F. | +2

65

Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma : a multicenter retrospective study

enthalten in: International journal of hematology | 2020

von Ito, A. | Kim, S. | Matsuoka, K. | +30

66

Two Episodes of Transfusion-related Acute Lung Injury (TRALI) Occurring within a Short Period

enthalten in: Internal medicine (Tokyo, Japan) | 2020

von Akagi, Y. | Murata, S. | Yamashita, Y. | +7

67

Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma : Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib

enthalten in: International journal of molecular sciences | 2020

von Yamashita, Y. | Morita, S. | Hosoi, H. | +10

68

Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study

enthalten in: International journal of hematology | 2020

von Ito, A. | Kim, S. | Matsuoka, K. | +30

69

Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study

enthalten in: International journal of hematology | 2020

von Ito, A. | Kim, S. | Matsuoka, K. | +30

70

Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression

enthalten in: Hematology reports | 2020

von Yamashita, Y. | Hori, Y. | Kosako, H. | +9